Rob Milnes BA(Hons), DipM
CEO
Rob brings 30 years of expertise in financing, developing, manufacturing, and launching medical device and digital health technologies, alongside executing successful exits.
Rob has run and advised a number of startup companies in the medical and digital health fields, raising significant finance, bringing novel technology to market, helping set up quality and regulatory systems, and acting as non-exec Chair, Director, and Investor Director, as well as hands-on operational CEO roles.
Prior to that he worked for Roche, Oxford Instruments, and was formerly a member of the Operations Board of Huntleigh Healthcare following the successful sale and integration of the Sonicaid Fetal Monitoring and Medilog Cardiology businesses.
His sector experience spans in-vitro diagnostic laboratory and point of care testing; cardiology; obstetrics; gynaecology; fertility; general women’s health; EMG, EEG and sleep neurology; and ophthalmology.